Carboplatin, nab-paclitaxel plus atezolizumab in IMpower 130 trial: new weapons beyond controversies.

Transl Cancer Res

Department of Specialized, Experimental and Diagnostic Medicine, S.Orsola-Malpighi University Hospital, Alma Mater Studiorum University of Bologna, Bologna, Italy.

Published: December 2019

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798162PMC
http://dx.doi.org/10.21037/tcr.2019.12.69DOI Listing

Publication Analysis

Top Keywords

carboplatin nab-paclitaxel
4
nab-paclitaxel atezolizumab
4
atezolizumab impower
4
impower 130
4
130 trial
4
trial weapons
4
weapons controversies
4
carboplatin
1
atezolizumab
1
impower
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!